AGENDIA AT MIAMI BREAST
Agendia will be at the 38th Miami Breast Cancer Conference

New Data Evaluating MammaPrint & BluePrint:
Agendia will be showcasing new data from ongoing clinical research evaluating the MammaPrint and BluePrint genomic tests
Join at Miami Breast from March 4-7, 2021
These data, which build upon existing clinical research that demonstrates the efficacy of MammaPrint and BluePrint testing to consistently inform optimal treatment planning, highlight Agendia’s many trials in progress that will ultimately impact patient treatment and outcomes. Agendia will be showcasing the following abstracts:

How to register & view our virtual booth:
FOR PROVEN RESULTS
Trusted by leading physicians and institutions around the world
For the US, Puerto Rico, and South America
Agendia Inc. USA
22 Morgan
Irvine, CA 92618
(888) 321-2732
customercare@agendia.com
For outside the Americas
Agendia NV
Radarweg 60
1043 NT Amsterdam
The Netherlands
customerservice@agendia.com
+31 (0)20 462 1510